Publication Name	World Journal of Gastroenterology
Manuscript ID	7789
Country	South Korea

Received	2013-11-30 14:50
Peer-Review Started	2013-11-30 21:54
To Make the First Decision	2013-12-26 11:12
Return for Revision	2013-12-27 08:13
Revised	2014-01-02 20:00
Second Decision	2014-04-09 09:17
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-04-09 10:31
Articles in Press	2014-05-23 11:01
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-04-26 19:59
Typeset the Manuscript	2014-09-14 17:30
Publish the Manuscript Online	2014-10-07 17:32

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Update on hepatitis B virus infection
Manuscript Source	Invited Manuscript
All Author List	Chan Ran You, Sung Won Lee, Jeong Won Jang and Seung Kew Yoon
Funding Agency and Grant Number
Corresponding Author	Seung Kew Yoon, M.D.& Ph.D. Professor Division of Hepatology Department of Internal Medicine, Seoul St.Mary’s Hospital College of Medicine, The Catholic University of Korea #505 Banpodong, Seocho-gu, 137-701, Seoul, South Korea Tel: 82-2-2258-7534 Fax: 82-2-536-9559 e-mail: yoonsk@catholic.ac.kr
Key Words	Hepatitis B virus; Chronic hepatitis B; Nucleos(t)ide analogue; Pegylated interferon; Antiviral therapy
Core Tip	The primary goal of chronic hepatitis B (CHB) treatment is to eradicate hepatitis B virus (HBV) or to at least maintain suppression of HBV replication. To this end, it is essential to better understand the immunopathogenesis of CHB, although it has yet to be further elucidated. More practically, it is of great importance to choose a potent antiviral drug with a low risk of resistance for initial treatment of CHB to achieve sustained virological response. This review highlights recent advances in the understanding of the immunopathogenesis of HBV and currently available and developing treatment strategies for HBV infection.
Publish Date	2014-10-07 17:32
Citation	You CR, Lee SW, Jang JW, Yoon SK. Update on hepatitis B virus infection. World J Gastroenterol 2014; 20(37): 13293-13305
URL	http://www.wjgnet.com/1007-9327/full/v20/i37/13293.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i37.13293

Full Article (PDF)	WJG-20-13293.pdf
Full Article (Word)	WJG-20-13293.doc
Manuscript File	7789-Review.docx
Answering Reviewers	7789-Answering reviewers.pdf
Copyright License Agreement	7789-Copyright assignment.pdf
Peer-review Report	7789-Peer review(s).pdf
Scientific Editor Work List	7789-Scientific editor work list.doc